Page 4 - CCfV-Annual-Report-2013-14

CCfV Funded Research 2013-14 Vision 9% CCfV is an integrated collaborative multidisciplinary vaccine research team committed 49% 24% to excellent research. CCfV unites the biomedical and clinical sciences with the social sciences and humanities to 18% efectively span the research continuum from basic discovery to translation into useful vaccines to prevent disease in humans and Canadian Institutes of Health Research and Other to change population and public Granting Agencies Funding $233,102 health outcomes. Industry Funding $590,308 PCIRN* CIHR Funding $437,856 PCIRN* Industry Funding $1,204,836 Organization Activity within CCfV is organized into three groups: PCIRN* Research 2013-14 • Vaccine Discovery Group • Vaccine Evaluation Group • Health Policy & 27% Translation Group An Advisory Committee of CCfV investigators and external 73% advisors provides counsel on the strategic direction and objectives of CCfV research. Canadian Institutes of Health Research Funding $437,856 Industry Funding $1,204,836 * Public Health Agency of Canada/Canadian Institutes of Health Research Infuenza Research Network * Dalhousie University is the lead institution for the Public Health Agency of Canada/Canadian Institutes of Health Research Infuenza Research Network (PCIRN). PCIRN funds are disbursed across Canada, facilitating research at over 30 institutions. 2 Canadian Center for Vaccinology